Opendata, web and dolomites


Functional and Molecular Characterisation of Breast Cancer Stem Cells

Total Cost €


EC-Contrib. €






 BRECASTEM project word cloud

Explore the words cloud of the BRECASTEM project. It provides you a very rough idea of what is the project "BRECASTEM" about.

lgr6    host    injury    mammary    aggressiveness    differences    play    observations    strategies    plasticity    unipotent    underlying    ultimate    pivotal    characterise    every    dramatically    organ    adult    tumour    cscs    event    laboratory    cellular    tumours    impaired    heterogeneous    self    progenitors    morphology    leucine    cancers    identities    contributed    cell    molecular    extensive    caused    progenitor    transforming    led    therapeutic    breast    puberty    mutations    luminal    protein    coupled    functional    gland    lineage    population    oncogenic    positive    eliminate    capacities    containing    homeostasis    hierarchy    regeneration    receptor    renewal    conversely    driving    mechanisms    cells    tissue    give    regenerate    deregulation    characterisation    mouse    differentiation    maintenance    proliferative    repeat    types    rare    harbours    occurring    replication    depletion    surface    phenotypically    transformed    carcinogenesis    undergoes    consisting    cancer    remodelling    function    harbour    incompletely    murine    pregnancy    postnatally    stem    unknown   

Project "BRECASTEM" data sheet

The following table provides information about the project.


Organization address
address: 1 MIDLAND ROAD
city: LONDON
postcode: NW1 1AT

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website cell-population-of-luminal-breast-cancer
 Total cost 183˙454 €
 EC max contribution 183˙454 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-03-01   to  2019-02-28


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

Every organ harbours adult stem cells which have the potential for long-term replication, together with the capacities of self-renewal and multi-lineage differentiation. These stem cells function in tissue homeostasis and contribute to regeneration in response to injury. In addition, many cancers are caused by transforming mutations occurring in tissue-specific progenitor cells. These transformed stem cells harbour long-term proliferative potential and the ability to regenerate tumours consisting of phenotypically heterogeneous cell types. The identities of cancer stem cells (CSCs) that give rise to breast tumours are incompletely understood.

The mammary gland is composed of a complex cellular hierarchy, which undergoes most of its development postnatally. To achieve this great plasticity, both stem and progenitor cells play a pivotal role in the extensive tissue remodelling occurring during puberty and pregnancy. Deregulation of stem and progenitor cells is a key event in mammary carcinogenesis. Recently, the host laboratory identified a rare unipotent progenitor cell population in the adult murine mammary gland characterized by the surface protein leucine-rich repeat-containing G-protein coupled receptor 6 (Lgr6). Oncogenic mutations in Lgr6-positive cells led to the formation of luminal mammary gland tumours, and contributed to tumour aggressiveness and maintenance. Conversely, depletion of Lgr6-positive progenitors in mouse luminal breast cancer dramatically impaired tumour growth and morphology. However, the underlying molecular mechanisms driving these observations are unknown.

The aim of this project is the characterisation of Lgr6-positive breast cancer stem cells, using functional and molecular approaches. We will characterise the molecular differences between cancer stem cells and non-stem cells, with the ultimate goal of identifying novel therapeutic strategies to eliminate breast cancer stem cells.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BRECASTEM" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BRECASTEM" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)


Digital Poetry in Today’s Russia: Canonisation and Translation

Read More  

ReproMech (2019)

The Molecular Mechanisms of Cell Fate Reprogramming in Vertebrate Eggs

Read More  

UNITE (2019)

Unification Through Law: The Court of Justice of the European Union as Cultural-Moral Agent

Read More